AX1.F Sipai Health Technology Co. Ltd.
- Market cap
- EUR 97.9M
- P/E
- -
- P/B
- 0.76x
- ROE
- -13.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is AX1.F undervalued?
Graham numberThe Graham number of Sipai Health Technology Co. Ltd. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sipai Health Technology Co. Ltd. fundamental analysis
No fundamental analysis for Sipai Health Technology Co. Ltd. yet.
Sipai Health Technology Co. Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sipai Health Technology Co. Ltd.
Sipai Health Technology Co., Ltd., together with its subsidiaries, operates as a medical technology and health management company in the People's Republic of China. It operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Commercial Insurance Services Business. The company operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. It also provides site man…
Full company profileSipai Health Technology Co. Ltd. financial statements
Sipai Health Technology Co. Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 3.47B | 4.12B | 4.71B | 4.57B | 2.07B |
| Gross Profit | 283M | 337M | 415M | 386M | 311M |
| Operating Income | -728M | -613M | -246M | -280M | -92.3M |
| EBITDA | - | -1.31B | -189M | -309M | -99.8M |
| Net Income | -3.74B | -1.37B | -256M | -324M | -124M |
| EPS | -4.90 | -1.80 | -0.34 | -0.42 | -0.17 |
| Balance Sheet | |||||
| Total Assets | 2.89B | 2.93B | 2.82B | 2.27B | 1.60B |
| Total Liabilities | 8.32B | 1.10B | 1.18B | 1.06B | 703M |
| Shareholders' Equity | -5.43B | 1.84B | 1.62B | 1.23B | 936M |
| Cash & Short-term Investments | 536M | 1.46B | 495M | 253M | 259M |
| Cash Flow | |||||
| Operating Cash Flow | -622M | -182M | -133M | -59.4M | 6.36M |
| Capital Expenditure | 21.4M | 11.8M | 5.75M | 10.7M | 6.23M |
| Free Cash Flow | -643M | -194M | -139M | -70.2M | 127K |
| Ratios | |||||
| ROE | - | -74.6% | -15.8% | -26.4% | -13.3% |
| ROA | -129.3% | -46.8% | -9.1% | -14.3% | -7.8% |
| Net Profit Margin | -107.7% | -33.3% | -5.4% | -7.1% | -6.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sipai Health Technology Co. Ltd. dividends
Sipai Health Technology Co. Ltd. has not paid dividends in the last 5 fiscal years.
Who owns Sipai Health Technology Co. Ltd.
- Insiders 57.42%
- Institutions 10.93%
- Public & others 31.65%
- Shares outstanding 725M
- Free float 376M
Sipai Health Technology Co. Ltd. company profile
- Company name
- Sipai Health Technology Co. Ltd.
- Ticker
- AX1.F
- ISIN
- KYG8192S1021
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Distribution
- Employees
- 3,449
- Fiscal year end
- December
- Address
- Tower 1, Kerry Enterprise Center, Shanghai, China
- Website
- medbankshealthtech.com
About Sipai Health Technology Co. Ltd.
Sipai Health Technology Co., Ltd., together with its subsidiaries, operates as a medical technology and health management company in the People's Republic of China. It operates through three segments: Specialty Pharmacy Business, Physician Research Assistance Business, and Commercial Insurance Services Business. The company operates specialty pharmacy stores; and distributes pharmaceutical products to pharmaceutical companies and other distributors. It also provides site management organization services, including site feasibility, site initiation, patient recruitment, patient management, data entry and document management, on-site drug management and bio-sample management, site closure, and other services to pharmaceutical companies and other clinical trial institutions; and services for image management in clinical trials. In addition, the company offers insurance brokerage services to insurance companies and health management services to insurance carriers and enterprise clients. Further, it is involved in retail of pharmaceutical products; and provision of pharmacist and physician research assistance services. The company was founded in 2014 and is based in Shanghai, the People's Republic of China.
Sipai Health Technology Co. Ltd. management
3- Mr. Xuguang MaCEO & Executive Chairman · born 1971
- Mr. Ji LiPresident & Executive Director · born 1978
- Ms. Na RenGeneral Counsel & Company Secretary · born 1978